Navigating Neuroendocrine Tumors

This chapter features a surgical oncologist's journey in the field of neuroendocrine tumors, highlighting the significance of mentorship and innovative treatments at the University of Iowa. The discussion emphasizes the MEN1 genetic test's role in assessing familial cancer risks and its implications for patient care, as well as the accuracy of the NET test in monitoring tumor recurrence. Complexities in diagnosis, particularly of small bowel tumors, are addressed, along with the importance of understanding genetic results for patient and family decision-making.